Corona Remedies IPO open date is December 8, 2025 and the IPO will close on December 10, 2025. Corona Remedies IPO is a Book Built Issue. The company to raise around ₹655.37 crores via IPO that comprises fresh issue of ₹[.] crores and offer for sale up to 61,71,101 equity shares with face value of ₹10 each.
Corona Remedies IPO price band is ₹1008 to ₹1062 per share. The retail quota is 35%, QIB is 50%, and HNI is 15%. Corona Remedies IPO to list on BSE, NSE on December 15, 2025. The allotment of Corona Remedies IPO date is December 11, 2025.
The company reported revenue of ₹1,202.35 crores in 2025 against ₹1,020.93 crores in 2024. The company reported profit of ₹149.43 crores in 2025 against profit of ₹90.50 crores in 2024. As per the financials the IPO investors should apply the IPO for a long term.
Corona Remedies IPO Details
Corona Remedies IPO Review & Key Points
- Review: May Apply
- Rating: —-
Corona Remedies IPO Market Lot
The Corona Remedies IPO minimum market lot is 14 shares with ₹14,868 application amount. The retail investors can apply up-to 13 lots with 182 shares of ₹1,93,284 amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 14 | ₹14,868 |
| Retail Maximum | 13 | 182 | ₹1,93,284 |
| S-HNI Minimum | 14 | 196 | ₹2,08,152 |
| S-HNI Maximum | 67 | 938 | ₹9,96,156 |
| B-HNI Minimum | 68 | 952 | ₹10,11,024 |
IPO Reservation
| Investor Category | Share Offered | -% Shares |
| Anchor Investor | 18,34,804 Shares | 29.73% |
| QIB (Ex. Anchor) | 12,21,729 Shares | 19.80% |
| NII Shares Offered | 9,16,960 Shares | 14.86% |
| Retail Shares Offered | 21,39,573 Shares | 34.67% |
Corona Remedies IPO Anchor Investors
————
Corona Remedies IPO Dates
The Corona Remedies IPO date is December 8 and the close date is December 10. The Corona Remedies IPO allotment will be finalized on December 11 and the IPO listing on December 15.
| IPO Open Date: | December 8, 2025 |
| IPO Close Date: | December 10, 2025 |
| Basis of Allotment: | December 11, 2025 |
| Refunds: | December 12, 2025 |
| Credit to Demat Account: | December 12, 2025 |
| IPO Listing Date: | December 15, 2025 |
| IPO Bidding Cut-off Time: | December 10, 2025 – 5 PM |
Promoters and Holding Pattern
The promoters of the company are Dr. Kirtikumar Laxmidas Mehta, Niravkumar Kirtikumar Mehta and Ankur Kirtikumar Mehta.
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 6,11,60,088 | 72.50% |
| Promoter Holding Post Issue | 6,11,60,088 | -% |
Objects of the Issue & Utilisation of proceeds
- NA
About Corona Remedies IPO
Founded in August 2004, Corona Remedies Limited is one of the leading pharmaceutical companies that is involved in manufacturing and selling products for women’s health, heart care, pain relief, urology, and other treatments. As per the report, among 30 others, Corona Remedies is the 2nd largest company in the Indian Pharmaceutical Market (“IPM”). Moreover, the company comprises a total of 88 R&D employees as of December 31, 2024.
The company offers 67 brands across various therapeutic areas, including women’s healthcare, cardio-diabeto, pain management, urology, and multispecialty pharmaceuticals (including vitamins/minerals/nutrition, gastrointestinal, and respiratory) as of December 2024. The company offers a pan-India presence with 2,598 medical representatives in 22 states. It comprises 2 manufacturing facilities located in the state of Gujarat.
Corona Remedies IPO Company Financial Report
Amount ₹ in Crores
| Period Ended | Revenue | Expense | PAT | Assets |
| 2023 | ₹891.10 | ₹756.07 | ₹84.93 | ₹595.02 |
| 2024 | ₹1,020.93 | ₹859.74 | ₹90.50 | ₹830.58 |
| 2025 | ₹1,202.35 | ₹956.44 | ₹149.43 | ₹929.86 |
| June 2025 | ₹348.56 | ₹276.76 | ₹46.20 | ₹1,012.38 |
Corona Remedies IPO Valuation – FY2025
Check Corona Remedies IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | 27.50% |
| ROCE: | 41.32% |
| EBITDA Margin: | 20.55% |
| PAT Margin: | 12.49% |
| Debt to equity ratio: | – |
| Earning Per Share (EPS): | ₹24.43 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 24.65% |
| Net Asset Value (NAV): | ₹99.14 |
Career Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Abbott India Limited | 665.62 | 54.28 | 33.41% | 1,992.14 | 6,409.15 Cr. |
| Alkem Laboratories Limited | 181.11 | 32.96 | 18.07% | 1,002.37 | 12,964.52 Cr. |
| Eris Lifesciences Limited | 25.85 | 47.99 | 12.21% | 209.73 | 2,893.64 Cr. |
| GlaxoSmithKline Pharmaceuticals Limited | 54.76 | 83.53 | 47.54% | 115.19 | 3,749.21 Cr. |
| J.B. Chemicals & Pharmaceuticals Limited | 42.45 | 47.21 | 19.21% | 220.88 | 3,917.99 Cr. |
| Mankind Pharma Limited | 49.28 | 54.17 | 13.89% | 352.51 | 12,207.44 Cr. |
| Pfizer Limited | 167.79 | 34.56 | 18.20% | 921.88 | 2,281.35 Cr. |
| Sanofi India Limited | 179.46 | 23.76 | 48.05% | 373.68 | 2,013.20 Cr. |
| Torrent Pharmaceuticals Limited | 56.47 | 66.51 | 25.18% | 224.28 | 11,516.09 Cr. |
IPO Lead Managers aka Merchant Bankers
- JM Financial Ltd. | IIFL Capital Services Ltd. | Kotak Mahindra Capital Co. Ltd.
Corona Remedies IPO FAQs
What is Corona Remedies IPO?
Corona Remedies IPO is Mainboard IPO. The company is going to raise ₹655.37 Crores via IPO. The issue is priced at ₹1008 to ₹1062 per equity share. The IPO is to be listed on BSE & NSE.
When Corona Remedies IPO will open for subscription?
The IPO is to open on December 8, 2025 for QIB, NII, and Retail Investors. The IPO will close on December 10, 2025.
What is Corona Remedies IPO Investors Portion?
The investors’ portion for QIB is 50%, NII is 15%, and Retail is 35%.
How to Apply the Corona Remedies IPO?
You can apply for Corona Remedies IPO via ASBA online via your bank account. You can also apply for ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form.
What is Corona Remedies IPO Issue Size?
Corona Remedies IPO issue size is ₹655.37 crores.
What is Corona Remedies IPO Price Band?
Corona Remedies IPO Price Band is ₹1008 to ₹1062.
What is Corona Remedies IPO Lot Size?
The minimum bid is 14 Shares with ₹14,868 amount.
What is the Corona Remedies IPO Allotment Date?
Corona Remedies IPO allotment date is December 11, 2025.
What is the Corona Remedies IPO Listing Date?
Corona Remedies IPO listing date is December 15, 2025. The IPO is to list on BSE & NSE.
Disclaimer: This content is provided strictly for educational and informational purposes. The securities or investments mentioned are not to be considered as investment advice or recommendations. The Investors are advised to do their own research or connect with a financial advisor before making any investment decisions.
